Member Info for checkricky

This is all coming together nicely 👌 and the skilled investors know hemogenyx is setting up very important stages for a low cost structure and a more attractive commercial setup, we all know the science has proved it works so give it the chance to deliver the goods. So chill the daily repetitive nonsense.

No one knows which day the RNS'S are going to land but what we do know is it's coming anyday now. So stick your money in or out very simple

Onwards & Upwards

Wow this is a bargain BUY at this low shareprice price considering we are on the cusp of big positive news anyday now..

Bargain all day long

Onwards & Upwards

So what's next?

Well we know yhe science works brilliantly and we all know we have so much to look forward to it's all looking very positive for 2026 and hemogenyx will deliver strong results in the next stage of the trials and with that very good returns for it's shareholders

Im Getting ready and into gear for the next big RNS it could be

Tech transfer completed update any day now

Patient 4 successfully treated

1st pediatric patient successfully treated

Patient 1 passed 1 year mark

Estonia project up and running

CDX, CBR the list is looking good

Not sure in which order but the amazing science will do the talking in 2026 that's for sure

Onwards & Upwards

Guys Dont reply to any unwanted or unwelcome posts from a few bad minded attention seekers....

Things have moved on now and this is not the same hemogenyx as it used to be.

So I say don't encourage or engage with just a few clowns. Let them go away like a bad unwanted fart smell...

Onwards and Upwards

Like I said most of us know we are "extremely close" to "BIG POSITIVE"news to landing any day now, stay focused don't get distracted by the bad minded few...

HEMOGENYX IS A STRONG BUY NOW OBVIOUSLY 💪

Onwards & Upwards

Most of us know we are extremely close to the BIG positive news to land any day now, stay focused don't get distracted by the bad minded few...

HEMOGENYX IS A STRONG BUY NOW OBVIOUSLY 💪

Onwards & Upwards

Great post from SocialistB yesterday 👏

After Estonia, could it be – Japan, here we come.

Japans Pharmaceuticals and Medical Devices Act (PMD Act) contains the Conditional and Time-Limited Approval pathway.

Unlike traditional drugs that require massive Phase III trials to prove efficacy before sale, this act allows approval based on preliminary clinical data that "predicts" efficacy, provided safety is confirmed.

In March 2026, Japan officially approved the world's first commercial stem-cell treatments derived from induced pluripotent stem (iPS) cells.

ReHeart (Cuorips Inc.): A treatment for severe heart failure caused by ischemic cardiomyopathy.

It involves placing coin-shaped "sheets" of heart muscle cells (grown from donor iPS cells) onto the patient's heart to stimulate new blood vessel growth and improve cardiac function.

Back to the Conditional and Time-Limited Approval pathway.

Could this be a way forward for HEMOGENYX and HG-CT-1in Japan?

For me, it looks like we should be able to qualify, based on what HG-CT-1 has proven so far in regard to safety and efficacy.

I think it is great that there are either more or alternate options out there.

The future is bright, at least that is how I see it.

Back Like a really unpleasant fart lol 😆

Thanks guys must say brilliant vidio on YouTube BBB11 and JH4H for link below. Good point just over 1 hour into video, Just shows the direction of where the clever money is moving into and its clear CAR-T THERAPY is go to benifit financially from big players

Now with the last trading day of February nearly out the way, will March be the mega month for Hemo investors

Onwards and Upwards

Would be amazing if we got a blockbuster RNS in the morning and the shareprice went up like a rocket 🚀

I'm just buying more and definitely not selling any shares until the next few RNS'S

With brokers fees and spread what a joker

The spread is a bit better now than fist thing in the morning 10% wtf..

Well this is a great buying opportunity for me, will be topping up today as we are into the last few trading day for February and will be into March for Monday's markets the question is will we get a positive RNS on Monday or Tuesday morning who knows... No rush for me

If you take the spread from yesterday and today's spread now one would make any money trading other than the mm. Even if you think your Mr or Mrs Smartie pants picking the top and bottom. I'm good holding 4 gold ✨️

Onwards & Upwards

This vidio sums up today's resident troll poster someone's not wanted in the team lol 😆

https://youtube.com/shorts/ZBSxmSdduoM?si=N9R6x872Lp0Jpfbd0

Can't believe the amazing maybe once in a lifetime opportunity in front of us that is all coming together nicely 👌

Honestly this is the time to stay focused 💯 % and not engage with the resident troll.

Green bin him and move on

We will all look back at this time and ask ourselves why did we get distracted by a single clown 🤡

Like I said now is a great time to be a Hemo shareholder

Spot on JH4H

You obviously haven't heard of NDA in you're professional world. Come on read the mood music its all positive and you will soon find out dude.

AI view HEMOGENYX is a "STRONG BUY"

HEMO Technical Analysis, RSI and Moving Averages - Investing.com https://share.google/iT0RmyA6hTXwMSEIS

AI view HEMOGENYX is a "STRONG BUY"

Hemogenyx Pharmaceuticals (LSE: HEMO) has recently reported significant operational and financial updates as it advances its clinical trials for blood diseases.

Latest Corporate & Financial News

Exercise of Warrants: On 23 February 2026, Hemogenyx announced the exercise of warrants over 50,841 new ordinary shares, raising approximately £118,632.

Share Admission: These new shares are expected to be admitted to trading on the London Stock Exchange on or around 27 February 2026. Following this, the company's total issued share capital will be 6,425,429 shares.

Major Holding Increase: A recent regulatory filing revealed David John Smith increased his voting rights to "10.28%" as of mid-February 2026, up from roughly 7% earlier in the month.

Fundraising: In early February 2026, the company raised funds to support its ongoing Phase I trials.

Clinical & Operational Progress

HG-CT-1 (CAR-T Therapy): The company is currently in the "final stages" of technology transfer work for its lead candidate, HG-CT-1, aimed at treating relapsed or refractory Acute Myeloid Leukemia (AML).

Pediatric Enrolment: In late 2025, Hemogenyx received clearance to begin pediatric enrolment for its Phase I trial, significantly expanding the treatment's potential reach.

CDX Antibody Development: Recent investor discussions highlight progress on an improved version of the CDX bi-specific antibody, utilizing Lonza’s bYlok technology to enhance scalability and manufacturing efficiency.

International Expansion: The company has signed a Letter of Intent with Cellin Technologies to explore the commercialisation and manufacture of its therapies in Estonia, positioning it for broader EU access.

Stock Performance Overview

Current Price: As of 24 February 2026, the stock closed at 1,140p, reflecting a "strong rising trend" over the past six months.

This is getting ready to take off like a rocket 🚀

This is a clear indicator if a successful business man has done his home work correctly and investment made, you don't need to be a rocket scientist to understand "why" would he invest big sums, understand the potential of what's to come.

Onwards & Upwards

Follow the dosh dude's

Onwards & Upwards